In prostate cancer, free β-catenin regulates AR as a result of activation of wingless (Wnt) signaling pathways [20], and activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway is thought to be an upstream regulator of this event. Here, AKT1 is linked to prostate cancer.